Literature DB >> 6282382

"Scalded mouth" caused by angiotensin-converting-enzyme inhibitors.

P H Vlasses, H H Rotmensch, R K Ferguson, S L Sheaffer.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6282382      PMCID： PMC1498640          DOI： 10.1136/bmj.284.6330.1672

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Aphthous ulcers of mouth from captopril.

Authors:  Y K Seedat
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

2.  Temporary ageusia related to captopril.

Authors:  P H Vlasses; R K Ferguson
Journal:  Lancet       Date:  1979-09-08       Impact factor: 79.321

3.  Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".

Authors:  H Gavras; J Biollaz; B Waeber; H R Brunner; I Gavras; R O Davies
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

4.  Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril.

Authors:  R K Ferguson; P H Vlasses
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

5.  Ulceration of the tongue: a complication of captopril therapy.

Authors:  M G Nicholls; A H Maslowski; H Ikram; E A Espiner
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391
  5 in total
  3 in total

Review 1.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 2.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 3.  Enalapril: a review of human pharmacology.

Authors:  H J Gomez; V J Cirillo; J D Irvin
Journal:  Drugs       Date:  1985       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.